Knockout of GPRC5A (G protein-coupled receptor family C, group 5, member A) reduced the proliferation and migration ability of pancreatic cancer cell lines and suppressed the resistance of pancreatic cancer cell lines to the chemotherapy drugs gemcitabine, oxaliplatin and fluorouracil [19]. The gene discussed is GPRC5A; the disease is pancreatic neoplasm.